Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Biostar Pharmaceuticals Zushima analgesic spray (Zushima spray) pain relief drug has received the "Army New Drug Certificate" from People's Liberation Army General Logistics department.
Subscribe to our email newsletter
The spray has been developed in cooperation with Lanzhou Military Institute of Drugs and Instruments to meet the China’s military needs.
Biostar constructed a plant and production line for Zushima spray in May 2012.
The analgesic spray will initially be sold in military hospitals and is expected to generate between $4m – $5m in 2013 revenues, according to Biostar.
Biostar is also seeking SFDA’s approval to make the spray available in the national market.
Biostar chief executive officer and chairman Ronghua Wang said Biostar is pleased that after completing several years of clinical trials, the company received the approval for Zushima’s Army New Drug Certificate.
”It marks an important milestone for Biostar as the Chinese military market represents a new opportunity for growth,” Wang added.
”Since last year, we have been cooperating with military universities such as The Fourth Military Medical University and have signed LOIs to conduct clinical trials for new products, which should enable us to become a producer of drugs specifically for the needs of China’s military."